Bartelme Amanda, Bridger Perry
Avalere Health, LLC Washington, DC 20036, USA.
J Diabetes Sci Technol. 2009 Jul 1;3(4):992-5. doi: 10.1177/193229680900300449.
Continuous glucose monitors are a clinically meaningful addition to treatment plans for patients with diabetes who are actively managing their care. Since they first became commercially available, much progress has been made to ensure coverage of these devices for patients, but inadequate reimbursement of clinicians' time continues to serve as a barrier to adoption.
连续血糖监测仪对于积极管理自身护理的糖尿病患者的治疗计划而言是一项具有临床意义的补充。自首次商业化上市以来，在确保这些设备覆盖患者方面已取得了很大进展，但临床医生时间补偿不足仍然是采用该设备的一个障碍。
